{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T16:04:11Z","timestamp":1773072251866,"version":"3.50.1"},"reference-count":30,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,8,1]]},"DOI":"10.2169\/internalmedicine.0302-17","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T22:26:40Z","timestamp":1520548000000},"page":"2227-2232","source":"Crossref","is-referenced-by-count":11,"title":["Anti-PL-7 Antisynthetase Syndrome with Eosinophilic Pleural Effusion"],"prefix":"10.2169","volume":"57","author":[{"given":"Go","family":"Saito","sequence":"first","affiliation":[{"name":"Department of Pulmonary Medicine, Seirei Hamamatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Kono","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Seirei Hamamatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akari","family":"Tsutsumi","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Seirei Hamamatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Koyanagi","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Seirei Hamamatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Miyashita","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Seirei Hamamatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Seirei Hamamatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironao","family":"Hozumi","sequence":"additional","affiliation":[{"name":"Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Miki","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Seirei Hamamatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Arai","sequence":"additional","affiliation":[{"name":"Department of Pathology, Seirei Hamamatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Otsuki","sequence":"additional","affiliation":[{"name":"Department of Pathology, Seirei Hamamatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Seirei Hamamatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Fujisawa","sequence":"additional","affiliation":[{"name":"Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of General Thoracic Surgery, Seirei Hamamatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Suda","sequence":"additional","affiliation":[{"name":"Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Seirei Hamamatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Mimori T, Imura Y, Nakashima R, et al. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance. Curr Opin Rheumatol 19: 523-529, 2007.","DOI":"10.1097\/BOR.0b013e3282f01a8c"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mirrakhimov AE. Antisynthetase syndrome: a review of etiopathogenesis, diagnosis and management. Curr Med Chem 22: 1963-1975, 2015.","DOI":"10.2174\/0929867322666150514094935"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Nakashima R, Imura Y, Hosono Y, et al. The multicenter study of a new assay for simultaneous detection of multiple anti-aminoacyl-tRNA synthetases in myositis and interstitial pneumonia. PLoS One 9: e85062, 2014.","DOI":"10.1371\/journal.pone.0085062"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hamaguchi Y, Fujimoto M, Matsushita T, et al. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. PLoS One 8: e60442, 2013.","DOI":"10.1371\/journal.pone.0060442"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hervier B, Devilliers H, Stanciu R, et al. Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. Autoimmun Rev 12: 210-217, 2012.","DOI":"10.1016\/j.autrev.2012.06.006"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Marie I, Josse S, Decaux O, et al. Comparison of long-term outcome between anti-Jo1- and anti-PL7\/PL12 positive patients with antisynthetase syndrome. Autoimmun Rev 11: 739-745, 2012.","DOI":"10.1016\/j.autrev.2012.01.006"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Bouros D, Pneumatikos I, Tzouvelekis A. Pleural involvement in systemic autoimmune disorders. Respiration 75: 361-371, 2008.","DOI":"10.1159\/000119051"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kalomenidis I, Light RW. Eosinophilic pleural effusions. Curr Opin Pulm Med 9: 254-260, 2003.","DOI":"10.1097\/00063198-200307000-00002"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Krenke R, Nasilowski J, Korczynski P, et al. Incidence and aetiology of eosinophilic pleural effusion. Eur Respir J 34: 1111-1117, 2009.","DOI":"10.1183\/09031936.00197708"},{"key":"10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000327200","volume":"83","author":"Y Oba","year":"2012","unstructured":"10. Oba Y, Abu-Salah T. The prevalence and diagnostic significance of eosinophilic pleural effusions: a meta-analysis and systematic review. Respiration 83: 198-208, 2012.","journal-title":"Respiration","ISSN":"https:\/\/id.crossref.org\/issn\/0025-7931","issn-type":"print"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Noguchi E, Uruha A, Suzuki S, et al. Skeletal muscle involvement in antisynthetase syndrome. JAMA Neurol 74: 992-999, 2017.","DOI":"10.1001\/jamaneurol.2017.0934"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Labirua-Iturburu A, Selva-O'Callaghan A, Vincze M, et al. Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature. Medicine 91: 206-211, 2012.","DOI":"10.1097\/MD.0b013e318260977c"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Marie I, Josse S, Decaux O, et al. Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome. Eur J Intern Med 24: 474-479, 2013.","DOI":"10.1016\/j.ejim.2013.01.002"},{"key":"14","unstructured":"14. Sato S, Hirakata M, Kuwana M, et al. Clinical characteristics of Japanese patients with anti-PL-7 (anti-threonyl-tRNA synthetase) autoantibodies. Clin Exp Rheumatol 23: 609-615, 2005."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yamasaki Y, Yamada H, Nozaki T, et al. Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis\/dermatomyositis. Arthritis Rheum 54: 2004-2009, 2006.","DOI":"10.1002\/art.21883"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Fujisawa T, Hozumi H, Kono M, et al. Prognostic factors for myositis-associated interstitial lung disease. PLoS One 9: e98824, 2014.","DOI":"10.1371\/journal.pone.0098824"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Debray MP, Borie R, Revel MP, et al. Interstitial lung disease in anti-synthetase syndrome: initial and follow-up CT findings. Eur J Radiol 84: 516-523, 2015.","DOI":"10.1016\/j.ejrad.2014.11.026"},{"key":"18","unstructured":"18. Roach DG, Salter WM. Polymyositis with pulmonary infiltrate and pleural effusion. Minn Med 63: 277-279, 281, 1980."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Miyata M, Fukaya E, Takagi T, et al. Two patients with polymyositis or dermatomyositis complicated with massive pleural effusion. Intern Med 37: 1058-1063, 1998.","DOI":"10.2169\/internalmedicine.37.1058"},{"key":"20","unstructured":"20. Araya J, Nagai T, Oda H, et al. Polymyositis-induced respiratory failure in the presence of antecedent pleural effusion. Nihon Kokyuki Gakkai Zasshi (J Jpn Respir Soc) 36: 713-716, 1998 (in Japanese)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Maeshima E, Nishimoto T, Yamashita M, Mune M, Yukawa S. Progressive systemic sclerosis-polymyositis overlap syndrome with eosinophilic pleural effusion. Rheumatol Int 23: 252-254, 2003.","DOI":"10.1007\/s00296-003-0297-0"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Iwai H, Koike R, Ogawa J, et al. Case of dermatomyositis complicated with massive pleural effusion that preceded the myopathy. Nihon Rinsho Meneki Gakkai Kaishi (Jpn J Clin Immunol) 25: 270-276, 2002 (in Japanese).","DOI":"10.2177\/jsci.25.270"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Mogulkoc N, Kabasakal Y, Ekren PK, Bishop PW. An unusual presentation of anti-Jo-1 syndrome, mimicking lung metastases, with massive pleural and pericardial effusions. J Clin Rheumatol 12: 90-92, 2006.","DOI":"10.1097\/01.rhu.0000209894.43413.67"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Sugie K, Tonomura Y, Ueno S. Characterization of dermatomyositis with coexistence of anti-Jo-1 and anti-SRP antibodies. Intern Med 51: 799-802, 2012.","DOI":"10.2169\/internalmedicine.51.6566"},{"key":"25","unstructured":"25. Wu Y, Chhaya S, Hurowitz B, Ardiles T, Carlson R. Clinically amyopathic dermatomyositis complicated by pleural effusion case report, literature review, and proposed mechanism. Bull Hosp Jt Dis (2013) 73: 217-220, 2015."},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Mohamed KH, Abdelhamid AI, Lee YC, et al. Pleural fluid levels of interleukin-5 and eosinophils are closely correlated. Chest 122: 576-580, 2002.","DOI":"10.1378\/chest.122.2.576"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Yoshifuji H, Fujii T, Kobayashi S, et al. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity 39: 233-241, 2006.","DOI":"10.1080\/08916930600622884"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Hozumi H, Enomoto N, Kono M, et al. Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis\/dermatomyositis-associated interstitial lung disease: a retrospective case control study. PLoS One 10: e0120313, 2015.","DOI":"10.1371\/journal.pone.0120313"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Hozumi H, Fujisawa T, Nakashima R, et al. Comprehensive assessment of myositis-specific autoantibodies in polymyositis\/dermatomyositis-associated interstitial lung disease. Respir Med 121: 91-99, 2016.","DOI":"10.1016\/j.rmed.2016.10.019"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Fujisawa T, Hozumi H, Kono M, et al. Predictive factors for long-term outcome in polymyositis\/dermatomyositis-associated interstitial lung diseases. Respir Investig 55: 130-137, 2017.","DOI":"10.1016\/j.resinv.2016.09.006"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/15\/57_0302-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,4]],"date-time":"2018-08-04T04:46:14Z","timestamp":1533357974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/15\/57_0302-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,1]]},"references-count":30,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0302-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,1]]}}}